X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Analytical Cellular Pathology

期刊標題檢索 ANAL CELL PATHO 最新評論: Review speed: 12.0 | Submission hit rate: 50.0 Emphasis research di... (2023-10-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Analytical Cellular Pathology]您好,您是該頁面的第 26466 位訪客。

期刊簡介
期刊名稱Analytical Cellular Pathology Analytical Cellular Pathology
LetPub Score
4.9
50 ratings
Rate

Reputation
5.9

Influence
3.6

Speed
7.0

期刊簡稱ANAL CELL PATHOL
ISSN2210-7177
E-ISSN2210-7185
h-index18
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.900.7110.546
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q254 / 208
Category: Medicine
Subcategory: Cancer Research
Q3136 / 230
Category: Medicine
Subcategory: Molecular Medicine
Q3112 / 178
Category: Medicine
Subcategory: Cell Biology
Q3194 / 285

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Analytical Cellular Pathology is a peer-reviewed, Open Access journal that provides a forum for scientists, medical practitioners and pathologists working in the area of cellular pathology. The journal publishes original research articles, review articles, and clinical studies related to cytology, carcinogenesis, cell receptors, biomarkers, diagnostic pathology, immunopathology, and hematology.
官方網站https://www.hindawi.com/journals/acp
在線稿件提交http://mts.hindawi.com/login/
開放訪問Yes
出版商Hindawi Limited
主題領域ONCOLOGY
出版國/地區NETHERLANDS
發行頻率
創刊年2010
每年文章數42每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( USD2000; )
APC waiver:Check Notes
Other charges: No
Keywords: cytopathology、pathology、cytology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ3144/205
ONCOLOGYSCIEQ3175/322
PATHOLOGYSCIEQ235/88
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2210-7177%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 16 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Analytical Cellular Pathology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Extracellular VesiclesH-index: 0

    CiteScore: 27.30
    AGING CELLH-index: 113

    CiteScore: 14.40
    Science SignalingH-index: 128

    CiteScore: 9.50
    Cell Death DiscoveryH-index: 0

    CiteScore: 8.30
    Stem Cell ReportsH-index: 55

    CiteScore: 10.50
    CELLULAR ONCOLOGYH-index: 31

    CiteScore: 10.30
    Frontiers in Cell and Developmental BiologyH-index: 0

    CiteScore: 9.70
    Stem Cell Reviews and ReportsH-index: 61

    CiteScore: 9.30
    Cell RegenerationH-index: 0

    CiteScore: 5.80
    Cell Adhesion & MigrationH-index: 0

    CiteScore: 6.40
    學科內最受檢索的期刊 頁面查看次數
    Oncotarget633967
    Frontiers in Cell and Developmental Biology202345
    Cell Death Discovery107020
    Stem Cell Reports81277
    Science Signaling65701
    Journal of Extracellular Vesicles44107
    CELLULAR ONCOLOGY35744
    Current Stem Cell Research & Therapy35005
    AGING CELL33549
    Stem Cell Reviews and Reports31738
  •  

    Analytical Cellular Pathology Analytical Cellular Pathology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Analytical Cellular Pathology] 的評論撰寫評論
作者: Byron Eddie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-13 12:29:36 評論於
Review speed: 12.0 | Submission hit rate: 50.0 Emphasis research direction: bioinformatics; Basic validation experience sharing: This journal is particularly garbage, advising everyone not to submit. I submitted the initial draft in February, received feedback in April, two reviewers were okay, and after answering their comments in early May, it was about to be accepted. However, the journal suddenly said there were problems with the peer review process after acceptance, and the assigned editor was a foreigner I didn't know. Then suddenly re-invited the assigned editor. This process lasted for several months, from May to October, and then re-invited reviewers. The last reviewer was very unfriendly, and although the three questions he raised were not difficult to answer, explain, or modify, he directly rejected the paper without giving a chance for revision, wasting nearly a year. The editor also rejected the paper without even looking at the content. The efficiency of the handling editor was extremely low. The reviewer's comments were replied a month ago, but it took them another month to process. Truly a garbage journal and publishing company. Disappointed with Hindawi, it's only a 3-point level journal. A reviewer made me feel like I submitted to a 10-point journal, most likely a Chinese reviewer
(0) 讚! | Byron Eddie

作者: Byron Eddie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-13 09:36:17 評論於
Do not submit to this magazine, they handle things very slowly, low efficiency of the editors, and no one is willing to review manuscripts. At the same time, Hindawi Publishing Corporation is now on edge, an article that was supposed to be accepted was abruptly rejected. It was only after a mysterious acceptance that problems were found in the peer review process, with the assigned editor being a foreigner and the reviewers unable to see the name. Despite this, they all agreed to accept it, but then another issue arose requiring finding a new editor and resubmission, wasting a lot of time
(0) 讚! | Byron Eddie

作者: 百花高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-20 17:13:56 評論於
Me too, what's happening now?
(0) 讚! | 百花高洁

作者: 西风佳怡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-21 22:04:21 評論於
Do you need the raw data?
(0) 讚! | 西风佳怡

作者: Alston DeQuincey


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-17 18:59:37 評論於
It has been a month, and I have been constantly switching between "submitted" and "AE invited." What's happening?
(0) 讚! | Alston DeQuincey

作者: 风陵山阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-21 13:39:55 評論於
Is it 4.1 now?
(0) 讚! | 风陵山阳

作者: Horace Watt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-11 19:47:04 評論於
How are things now?
(0) 讚! | Horace Watt

作者: Horace Watt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-11 08:41:21 評論於
It has been 2 months and they are still inviting reviewers
(0) 讚! | Horace Watt

作者: Otis Harrington


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-02 10:34:12 評論於
Review speed: 1.0 | Submission hit rate: 75.0 Experience sharing: This journal has a relatively low impact factor, it is in the fourth district of the Chinese Academy of Sciences, and there are not many discussions. Let me give you a timeline: 3.26 submitted; 3.29 Under Review; 4.14 Revision requested; 4.16 Status immediately changed to Under Review after the first revision; 4.22 Reviewers invited; 5.10 Revision requested; 5.18 Status immediately changed to Under Review after the second revision; 7.31 Revision requested; 8.3 Third revision; 8.4 pending approval; 8.5 accepted. I have a question, I don't know if anyone else has encountered it, each of my three revisions only had one reviewer's opinion, I don't know if it's hard to find reviewers. But finally it's over ?
(0) 讚! | Otis Harrington

作者: 一条小嘉蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-19 10:37:45 評論於
I have been waiting for 20 days and still have not received any feedback from the editor
(0) 讚! | 一条小嘉蕊

作者: 晶瑶公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-30 20:58:59 評論於
Review speed: 2.0 | Submission acceptance rate: 75.0
Experience sharing: A routine bioinformatics article with a simple PCR validation, accepted in a month and a half, very fast
(0) 讚! | 晶瑶公子

作者: Otis Harrington


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-14 15:12:39 評論於
Hello, how is your article coming along now?
(0) 讚! | Otis Harrington

作者: 天池沛珊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-10 11:48:25 評論於
Review Speed: 24.0 | Submission Success Rate: 5.0 Experience Sharing: I submitted a paper in September last year, and it is now in the third round of reviews. The reviewers are still being invited. In the second round, one reviewer agreed to publish and another gave positive feedback with minor revisions. However, it has been a month since the revisions were submitted, and reviewers are still being invited
(0) 讚! | 天池沛珊

作者: 心慈小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-09 10:01:43 評論於
How long is the review process usually?
(0) 讚! | 心慈小姐姐

作者: 北海振英


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-31 21:04:31 評論於
Today is the first day of submission and the status is Under Review. Good luck!
(0) 讚! | 北海振英

作者: 风啸梦玲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-02 10:28:45 評論於
Does the first trial take 3 months?
(0) 讚! | 风啸梦玲

作者: 巴蜀红螺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-14 16:26:52 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0 Experience sharing: 1.076
(0) 讚! | 巴蜀红螺

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Analytical Cellular Pathology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*